3.23.1 html 159 220 1 false 61 0 false 4 false false R1.htm 0000001 - Document - Cover Sheet http://vtvtherapeutics.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Operations - Unaudited Sheet http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited Condensed Consolidated Statements of Operations - Unaudited Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statement of Changes in Redeemable Noncontrolling Interest and Stockholders' Deficit - Unaudited Sheet http://vtvtherapeutics.com/role/CondensedConsolidatedStatementofChangesinRedeemableNoncontrollingInterestandStockholdersDeficitUnaudited Condensed Consolidated Statement of Changes in Redeemable Noncontrolling Interest and Stockholders' Deficit - Unaudited Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows - Unaudited Sheet http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows - Unaudited Statements 6 false false R7.htm 0000007 - Disclosure - Description of Business, Basis of Presentation and Going Concern Sheet http://vtvtherapeutics.com/role/DescriptionofBusinessBasisofPresentationandGoingConcern Description of Business, Basis of Presentation and Going Concern Notes 7 false false R8.htm 0000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://vtvtherapeutics.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 0000009 - Disclosure - Collaboration Agreements Sheet http://vtvtherapeutics.com/role/CollaborationAgreements Collaboration Agreements Notes 9 false false R10.htm 0000010 - Disclosure - Share-Based Compensation Sheet http://vtvtherapeutics.com/role/ShareBasedCompensation Share-Based Compensation Notes 10 false false R11.htm 0000011 - Disclosure - Investments Sheet http://vtvtherapeutics.com/role/Investments Investments Notes 11 false false R12.htm 0000012 - Disclosure - Commitments and Contingencies Sheet http://vtvtherapeutics.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 12 false false R13.htm 0000013 - Disclosure - Leases Sheet http://vtvtherapeutics.com/role/Leases Leases Notes 13 false false R14.htm 0000014 - Disclosure - Redeemable Noncontrolling Interest Sheet http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterest Redeemable Noncontrolling Interest Notes 14 false false R15.htm 0000015 - Disclosure - Stockholders' Deficit Sheet http://vtvtherapeutics.com/role/StockholdersDeficit Stockholders' Deficit Notes 15 false false R16.htm 0000016 - Disclosure - Related-Party Transactions Sheet http://vtvtherapeutics.com/role/RelatedPartyTransactions Related-Party Transactions Notes 16 false false R17.htm 0000017 - Disclosure - Income Taxes Sheet http://vtvtherapeutics.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 0000018 - Disclosure - Net Loss per Share Sheet http://vtvtherapeutics.com/role/NetLossperShare Net Loss per Share Notes 18 false false R19.htm 0000019 - Disclosure - Fair Value of Financial Instruments Sheet http://vtvtherapeutics.com/role/FairValueofFinancialInstruments Fair Value of Financial Instruments Notes 19 false false R20.htm 0000020 - Disclosure - Subsequent Events Sheet http://vtvtherapeutics.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 0000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://vtvtherapeutics.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://vtvtherapeutics.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 0000022 - Disclosure - Collaboration Agreements (Tables) Sheet http://vtvtherapeutics.com/role/CollaborationAgreementsTables Collaboration Agreements (Tables) Tables http://vtvtherapeutics.com/role/CollaborationAgreements 22 false false R23.htm 0000023 - Disclosure - Share-Based Compensation (Tables) Sheet http://vtvtherapeutics.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://vtvtherapeutics.com/role/ShareBasedCompensation 23 false false R24.htm 0000024 - Disclosure - Investments (Tables) Sheet http://vtvtherapeutics.com/role/InvestmentsTables Investments (Tables) Tables http://vtvtherapeutics.com/role/Investments 24 false false R25.htm 0000025 - Disclosure - Leases (Tables) Sheet http://vtvtherapeutics.com/role/LeasesTables Leases (Tables) Tables http://vtvtherapeutics.com/role/Leases 25 false false R26.htm 0000026 - Disclosure - Redeemable Noncontrolling Interest (Tables) Sheet http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterestTables Redeemable Noncontrolling Interest (Tables) Tables http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterest 26 false false R27.htm 0000027 - Disclosure - Net Loss per Share (Tables) Sheet http://vtvtherapeutics.com/role/NetLossperShareTables Net Loss per Share (Tables) Tables http://vtvtherapeutics.com/role/NetLossperShare 27 false false R28.htm 0000028 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://vtvtherapeutics.com/role/FairValueofFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://vtvtherapeutics.com/role/FairValueofFinancialInstruments 28 false false R29.htm 0000029 - Disclosure - Description of Business, Basis of Presentation and Going Concern (Detail) Sheet http://vtvtherapeutics.com/role/DescriptionofBusinessBasisofPresentationandGoingConcernDetail Description of Business, Basis of Presentation and Going Concern (Detail) Details http://vtvtherapeutics.com/role/DescriptionofBusinessBasisofPresentationandGoingConcern 29 false false R30.htm 0000030 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 30 false false R31.htm 0000031 - Disclosure - Collaboration Agreements - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/CollaborationAgreementsAdditionalInformationDetail Collaboration Agreements - Additional Information (Detail) Details 31 false false R32.htm 0000032 - Disclosure - Collaboration Agreements - Summary of Contract Liabilities Related to Company's Collaboration Agreements (Detail) Sheet http://vtvtherapeutics.com/role/CollaborationAgreementsSummaryofContractLiabilitiesRelatedtoCompanysCollaborationAgreementsDetail Collaboration Agreements - Summary of Contract Liabilities Related to Company's Collaboration Agreements (Detail) Details 32 false false R33.htm 0000033 - Disclosure - Collaboration Agreements - Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes (Details) Sheet http://vtvtherapeutics.com/role/CollaborationAgreementsContractwithCustomerContractAssetContractLiabilityandReceivableChangesDetails Collaboration Agreements - Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes (Details) Details 33 false false R34.htm 0000034 - Disclosure - Share-Based Compensation - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/ShareBasedCompensationAdditionalInformationDetail Share-Based Compensation - Additional Information (Detail) Details 34 false false R35.htm 0000035 - Disclosure - Share-Based Compensation - Summary of Stock Award Activity for the Period (Detail) Sheet http://vtvtherapeutics.com/role/ShareBasedCompensationSummaryofStockAwardActivityforthePeriodDetail Share-Based Compensation - Summary of Stock Award Activity for the Period (Detail) Details 35 false false R36.htm 0000036 - Disclosure - Share-Based Compensation - Summary of Compensation Expense Related to Grants of Stock Options (Detail) Sheet http://vtvtherapeutics.com/role/ShareBasedCompensationSummaryofCompensationExpenseRelatedtoGrantsofStockOptionsDetail Share-Based Compensation - Summary of Compensation Expense Related to Grants of Stock Options (Detail) Details 36 false false R37.htm 0000037 - Disclosure - Investments - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 37 false false R38.htm 0000038 - Disclosure - Investments - Schedule of Equity Investments with and without Readily Determinable Fair Values Assessed (Detail) Sheet http://vtvtherapeutics.com/role/InvestmentsScheduleofEquityInvestmentswithandwithoutReadilyDeterminableFairValuesAssessedDetail Investments - Schedule of Equity Investments with and without Readily Determinable Fair Values Assessed (Detail) Details 38 false false R39.htm 0000039 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/CommitmentsandContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 39 false false R40.htm 0000040 - Disclosure - Leases - (Details) Sheet http://vtvtherapeutics.com/role/LeasesDetails Leases - (Details) Details 40 false false R41.htm 0000041 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities for Operating Leases (Detail) Sheet http://vtvtherapeutics.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesforOperatingLeasesDetail Leases - Schedule of Maturities of Lease Liabilities for Operating Leases (Detail) Details 41 false false R42.htm 0000042 - Disclosure - Redeemable Noncontrolling Interest - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterestAdditionalInformationDetail Redeemable Noncontrolling Interest - Additional Information (Detail) Details 42 false false R43.htm 0000043 - Disclosure - Redeemable Noncontrolling Interest - Summary of Net Income Attributable to Vtv Therapeutics Inc (Detail) Sheet http://vtvtherapeutics.com/role/RedeemableNoncontrollingInterestSummaryofNetIncomeAttributabletoVtvTherapeuticsIncDetail Redeemable Noncontrolling Interest - Summary of Net Income Attributable to Vtv Therapeutics Inc (Detail) Details 43 false false R44.htm 0000044 - Disclosure - Stockholders' Deficit - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/StockholdersDeficitAdditionalInformationDetail Stockholders' Deficit - Additional Information (Detail) Details 44 false false R45.htm 0000045 - Disclosure - Related-Party Transactions - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related-Party Transactions - Additional Information (Detail) Details 45 false false R46.htm 0000046 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://vtvtherapeutics.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 46 false false R47.htm 0000047 - Disclosure - Net Loss per Share - Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss per Share of Class A Common Stock (Detail) Sheet http://vtvtherapeutics.com/role/NetLossperShareReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetLossperShareofClassACommonStockDetail Net Loss per Share - Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss per Share of Class A Common Stock (Detail) Details 47 false false R48.htm 0000048 - Disclosure - Net Loss per Share - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss per Share (Detail) Sheet http://vtvtherapeutics.com/role/NetLossperShareScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossperShareDetail Net Loss per Share - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss per Share (Detail) Details 48 false false R49.htm 0000049 - Disclosure - Fair Value of Financial Instruments - Summarizes the Conclusions Reached Regarding Fair Value Measurements (Detail) Sheet http://vtvtherapeutics.com/role/FairValueofFinancialInstrumentsSummarizestheConclusionsReachedRegardingFairValueMeasurementsDetail Fair Value of Financial Instruments - Summarizes the Conclusions Reached Regarding Fair Value Measurements (Detail) Details 49 false false R50.htm 0000050 - Disclosure - Fair Value of Financial Instruments - Fair Value Measurement Inputs and Valuation Techniques (Detail) Sheet http://vtvtherapeutics.com/role/FairValueofFinancialInstrumentsFairValueMeasurementInputsandValuationTechniquesDetail Fair Value of Financial Instruments - Fair Value Measurement Inputs and Valuation Techniques (Detail) Details 50 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. vtvt-20230331.htm 4 [dq-0542-Deprecated-Concept] Concept InvestmentsInAndAdvancesToAffiliatesBalanceShares in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. vtvt-20230331.htm 4 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: vtvt:MaximumFundingPercentageOfResearchAndDevelopmentMilestones - vtvt-20230331.htm 4 vtvt-20230331.htm vtvt-20230331.xsd vtvt-20230331_cal.xml vtvt-20230331_def.xml vtvt-20230331_lab.xml vtvt-20230331_pre.xml vtvt-20230331xexx311.htm vtvt-20230331xexx312.htm vtvt-20230331xexx321.htm vtvt-20230331xexx322.htm vtvt-20230331_g1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true